albuterol has been researched along with Emphysema in 6 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Emphysema: A pathological accumulation of air in tissues or organs.
Excerpt | Relevance | Reference |
---|---|---|
"We studied 21 COPD patients in stable clinical conditions to evaluate whether changes in lung function induced by cumulative doses of salbutamol alter diffusing capacity for carbon monoxide (DL(CO)), and whether this relates to the extent of emphysema as assessed by high resolution computed tomography (HRCT) quantitative analysis." | 5.12 | Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease. ( Baldi, S; Brusasco, V; Bruschi, C; Dore, R; Fracchia, C; Maestri, R; Pellegrino, R, 2006) |
"Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and responses to therapies are highly variable." | 1.37 | Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. ( Chae, EJ; Huh, JW; Kim, EK; Kim, TH; Kim, WJ; Lee, JH; Lee, JS; Lee, S; Lee, SD; Lee, SM; Lee, YK; Lim, SY; Oh, YM; Ra, SW; Seo, JB; Sheen, SS; Shin, TR; Yoon, HI, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, MK | 1 |
Wise, R | 1 |
Mumford, J | 1 |
Sciurba, F | 1 |
Criner, GJ | 1 |
Curtis, JL | 1 |
Murray, S | 1 |
Sternberg, A | 1 |
Weinman, G | 1 |
Kazerooni, E | 1 |
Fishman, AP | 1 |
Make, B | 1 |
Hoffman, EA | 1 |
Mosenifar, Z | 1 |
Martinez, FJ | 1 |
Hansen, JE | 1 |
Lee, JS | 1 |
Huh, JW | 1 |
Chae, EJ | 1 |
Seo, JB | 1 |
Ra, SW | 1 |
Lee, JH | 2 |
Kim, EK | 1 |
Lee, YK | 1 |
Kim, TH | 1 |
Kim, WJ | 1 |
Lee, SM | 1 |
Lee, S | 1 |
Lim, SY | 1 |
Shin, TR | 1 |
Yoon, HI | 1 |
Sheen, SS | 1 |
Oh, YM | 1 |
Lee, SD | 1 |
Luks, AM | 1 |
Goss, CH | 1 |
Schoene, RB | 1 |
Swenson, ER | 1 |
Baldi, S | 1 |
Fracchia, C | 1 |
Bruschi, C | 1 |
Dore, R | 1 |
Maestri, R | 1 |
Brusasco, V | 1 |
Pellegrino, R | 1 |
O'Donnell, DE | 1 |
Forkert, L | 1 |
Webb, KA | 1 |
2 trials available for albuterol and Emphysema
Article | Year |
---|---|
Prevalence and clinical correlates of bronchoreversibility in severe emphysema.
Topics: Aged; Albuterol; Bronchodilator Agents; Emphysema; Female; Humans; Logistic Models; Male; Nebulizers | 2010 |
Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Carbon Monoxide; Emphysema; Fema | 2006 |
4 other studies available for albuterol and Emphysema
Article | Year |
---|---|
Assessment of bronchoreversibility in severe emphysema.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Bronchodilator Agents; Emphysema; Female; Forced Exp | 2010 |
Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Androstadienes; Bronchodilator Agents; Emphysema; Female; Fluticasone; Humans; Line | 2011 |
A patient with vanishing lung syndrome and remarkable tolerance to high altitude.
Topics: Adrenergic beta-Agonists; Albuterol; Altitude; Androstadienes; Blister; Bronchodilator Agents; Choli | 2007 |
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
Topics: Aged; Albuterol; Bronchodilator Agents; Emphysema; Female; Forced Expiratory Volume; Functional Resi | 2001 |